Fuji Pharma Co., Ltd. (FRA:FUP)

Fuji Pharma Revenue

Fuji Pharma had revenue of 12.86B JPY in the quarter ending June 30, 2025, with 9.28% growth. This brings the company's revenue in the last twelve months to 49.94B, up 12.06% year-over-year. In the fiscal year ending September 30, 2024, Fuji Pharma had annual revenue of 46.14B with 12.84% growth.

• Revenue (ttm): 49.94B JPY
• Revenue Growth: +12.06%
• P/S Ratio: 0.75
• Revenue / Employee: 30.12M JPY
• Employees: 1,658
• Market Cap: 220.53M EUR

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	46.14B	5.25B	12.84%
Sep 30, 2023	40.89B	5.46B	15.42%
Sep 30, 2022	35.43B	1.44B	4.22%
Sep 30, 2021	33.99B	197.00M	0.58%
Sep 30, 2020	33.79B	-2.49B	-6.85%